Intraoperatorive hydroxyethyl starch: A safe therapy or a poison?;Almidones intraoperatorios: ¿medicamentos o venenos?

Revista Espanola de Anestesiologia y Reanimacion

Volumn 63, Issue 10, 2016, Pages 588-593

  Una Orejon R ^a   del Huercio Martinez, I ^a   Casinello Ogea, C ^b   del Prado Ureta Tolsada, M ^a   Una Orejon S ^c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH DERIVATIVE; PLASMA SUBSTITUTE;

FLUID THERAPY; HUMAN; PEROPERATIVE CARE;

FLUID THERAPY; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; INTRAOPERATIVE CARE; PLASMA SUBSTITUTES;

EID: 84964627202     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redar.2016.03.003     Document Type: Article

References (47)

1. 1 Chappell, D., Jacob, M., Hofmann-Kiefer, K., Conzen, P., Rehm, M., A rational approach to perioperative fluid management. Anesthesiology 109 (2008), 723–740.
2. 2 Perner, A., Haase, N., Guttormsen, A.B., Tenhunen, J., Klemenzson, G., Åneman, A.N., Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis (6S). Engl J Med 367 (2012), 124–134.
3. 3 Myburgh, J.A., Finfer, S., Bellomo, R., Billot, L., Cass, A., Gattas, D., Hydroxyethyl starch or saline for fluid resuscitation in intensive care (CHEST Study). N Engl J Med 367 (2012), 1901–1911.
4. 4 Dellinger, R.P., Levy, M.M., Rhodes, A., Annane, D., Gerlach, H., Opal, S.M., Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 41 (2013), 580–637.
5. 5 Bellomo, R., Bion, J., Finfer, S., Myburgh, J., Perner, A., Reinhart, K., Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth 112 (2014), 595–600.
6. 6 Guidet, B., Martinet, O., Boulain, T., Philippart, F., Poussel, J.F., Maizel, J., et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care, 16, 2012, R94.
7. 7 James, M.F., Michell, W.L., Joubert, A., Nicol, A.J., Navsaria, P.H., Gillespie, R.S., Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 107 (2011), 693–702.
8. 8 Annane, D., Siami, S., Jaber, S., Martin, C., Elatrous, S., Declère, A.D., et al. Effects of fluid resuscitation with colloids vs. crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 310 (2013), 1809–1817.
9. 9 Shaw, A.D., Bagshaw, S.M., Goldstein, S.L., Scherer, L.A., Duan, M., Schermer, C.R., et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 255 (2012), 821–829.
10. 10 Chowdhury, A.H., Cox, E.F., Francis, S.T., Lobo, D.N., A randomized, controlled, double-blind crossover study on the effects of 2-L infusion of 0.9% saline and Plasma-Lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 256 (2012), 18–24.
11. 11 Myburgh, J.A., Mythen, M.G., Resuscitation fluids. N Engl J Med 369 (2013), 1243–1251.
12. 12 Kragelund, E., Changes of the apparent 3HOH, 82Br, 125I human albumin and 51Cr red blood cell dilution volumes before, during and after operation in human subjects. Ann Surg 172 (1970), 116–124.
13. 4). Scand J Clin Lab Invest 19 (1967), 319–324.
14. 14 Hamilton, M.A., Cecconi, M., Rhodes, A., A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg 112 (2011), 1392–1402.
15. 15 Michard, F., Stroke volume variation: from applied physiology to improved outcomes. Crit Care Med 39 (2011), 402–403.
16. 16 Volta, C.A., Alvisi, V., Campi, M., Marangoni, E., Alvisi, R., Castellazzi, M., et al. Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study. Anesthesiology 106 (2007), 85–91.
17. 17 Marik, P.E., Monnet, X., Teboul, J.L., Hemodynamic parameters to guide fluid therapy. Ann Intensive Care, 1, 2011, 1.
18. 18 Marik, P.E., Baram, M., Vahid, B., Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 134 (2008), 172–178.
19. 19 Brienza, N., Giglio, M.T., Marucci, M., Fiore, T., Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med 37 (2009), 2079–2090.
20. 20 Dalfino, L., Giglio, M.T., Puntillo, F., Marucci, M., Brienza, N., Haemodynamic goal-directed therapy and postoperative infections: earlier is better. A systematic review and metaanalysis. Crit Care, 15, 2011, R154.
21. 21 Powell-Tuck, J.G.P., Lobo, D.N., Allison, S.P., Carlson, G.L., Gore, M., Lewington, A.J., British Consensus Guidelines on intravenous fluid therapy for adult surgical patients. 2011 http://www.bapenorguk/pdfs/bapen_pubs/giftasuppdf.
22. 22 Woodcock, T.E., Woodcock, T.M., Revised Starling equation and glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anest 108 (2012), 384–394.
23. 23 Casati, A., Fanelli, G., Pietropaoli, P., Proietti, R., Tufano, R., Danelli, G., et al. Continuous monitoring of cerebral oxygen saturation in elderly patients undergoing major abdominal surgery minimizes brain exposure to potential hypoxia. Anesth Analg 101 (2005), 740–747.
24. 24 Murkin, J.M., Adams, S.J., Novick, R.J., Quantz, M., Bainbridge, D., Igesias, I., et al. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg 104 (2007), 51–58.
25. 25 Slater, J.P., Guarino, T., Stack, J., Vinod, K., Bustami, R.T., Browm, J.M., et al. Cerebral oxygen desaturation predicts cognitive decline and longer hospital stay after cardiac surgery. Ann Thorac Surg 87 (2009), 36–44.
26. 26 Van Der Linden, P., James Michael Mythen, M., Weiskopf, R.B., Safety of modern starches used during surgery. Anesth Analg 116 (2013), 35–48.
27. 27 Van der Linden, P., Dumoulin, M., Van Lerberghe, C., Sanchez Torres, C., Willems, A., Faraoni, D., Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis. Crit Care, 2015, 1–11.
28. 28 Martin, C., Jacob, M., Vicaut, E., Guidet, B., van Aken, H., Kurz, A., Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 118 (2013), 387–394.
29. 29 Gillies, M.A., Habicher, M., Jhanji, S., Sander, M., Mythen, M., Hamilton, M., et al. Incidence of postoperative death and acute kidney injury associated with iv 6% hydroxyethil starch use: systematic review and meta-analysis. Br J Anesth 112 (2014), 25–34.
30. 30 Wilkes, M.M., Navickis, R.J., Postoperative renal replacement therapy after hydroxyethyl starch infusión: a meta-analysis of randomized trials. Neth J Crit Care 18 (2014), 4–9.
31. 31 He, B., Xu, B., Xu, X., Li, L., Ren, R., Chen, Z., et al. Hydroxyethyl starch versus other fluids for non-septic patients in the intensive care unit: a meta-analysis of randomized controlled trials. Crit Care, 19, 2015, 92.
32. 32 Brandstrup, B., Svendsen, B., Rasmussen, M., Belhage, B., Rodt, S.A., Hansen, B., et al. Which goal for fluid therapy during colorectal surgery is followed by the best outcome: near-maximal stroke volumen or zero fluid balance?. Br J Anaesth 109 (2012), 191–199.
33. 33 Moretti, E.W., Robertson, K.M., El-Moalem, H., Gan, T.J., Intraoperative colloid administration reduces postoperative nausea and vomiting and improves postoperative outcomes compared with crystalloid administration. Anaesth Analg 97 (2003), 611–617.
34. 34 Mythen, M.G., Postoperative gastrointestinal tract dysfunction. Anaesth Analg 100 (2005), 196–204.
35. 35 Yates, D.R., Davies, S.F., Milner, H.E., Wilson, R.T.J., Crystalloid or colloid for goal-directed fluid therapy in colorectal surgery. Br J Anaesth 114 (2014), 281–289.
36. 36 Zeng, K., Li, Y., Liang, M., Gao, Y., Cai, H., Lin, C., The influence of goal-directed fluid therapy on the prognosis of elderly patients with hypertension and gastric cancer surgery. Drug Des Devel Ther 8 (2014), 2113–2119.
37. 37 Kancir, A.S., Johansen, J.K., Ekeloef, N.P., Pedersen, E.B., The effect of 6% hydroxyethyl starch 130/0.4 on renal function, arterial blood pressure, and vasoactive hormones during radical prostatectomy: a randomized controlled trial. Anesth Analg 120 (2015), 608–618.
38. 38 Kimberger, O., Arnberger, M., Brandt, S., Plock, J., Sigurdsson, G.H., Kurz, A., et al. Goal-directed colloid administration improves the microcirculation of healthy and perianastomotic colon. Anesthesiology 110 (2009), 231–240.
39. 39 Cui, Y., Sun, B., Wang, C., Liu, S., Li, P., Shi, J., et al. Effects of different types of hydroxyethyl starch (HES) on microcirculation perfusion and tissue oxygenation in patients undergoing liver surgery. Int J Clin Exp Med 7 (2014), 631–639 www.ijcem.com/ISSN:1940-5901/IJCEM1401019.
40. 40 Legendre, C., Thervet, E., Page, B., Percheron, A., Noël, L.H., Kreis, H., Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 342 (1993), 248–249.
41. 41 Cittanova, M.L., Leblanc, I., Legendre, C., Mouquet, C., Riou, B., Coriat, P., Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348 (1996), 1620–1622.
42. 42 Blasco, V., Leone, M., Antonini, F., Geissler, A., Albanèse, J., Martin, C., Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain dead donor resuscitation on renal function after transplantation. Br J Anaesth 100 (2008), 504–508.
43. 43 Patel, M.S., Niemann, C.U., Sally, M.B., De La Cruz, S., Zatarain, J., Ewing, T., et al. The impact of hydroxyethyl starch use in deceased organ donors on the development of delayed graft function in kidney transplant recipients: a propensity-adjusted analysis. Am J Transplant 15 (2015), 2152–2158.
44. 44 Sánchez, C.A., Asuero, M.S., Controversias sobre la utilización de las soluciones de almidón (hidroxietil-almidones). ¿Está contraindicado el uso de hidroxietil-almidones de bajo peso molecular?. Rev Esp Anestesiol Reanim 61 (2014), 299–303.
45. 45 Heler, M., Arnemann, P.H., Ertmer, C., To use or not to use hydroxyethyl starch in intraoperative care: are we ready to answer the ‘Gretchen question’?. Curr Opin Anaesthesiol, 2015.
46. 46 Feldheiser, A., Pavlova, V., Bonomo, T., Jones, A., Fotopoulou, C., Sehouli, J., et al. Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm. Br J Anaesth 110 (2013), 231–240.
47. 47 Krebbel, H., Feldheiser, A., Muller, O., Boemke, W., Sander, M., Carsten, P., et al. Influence of goal-directed therapy with balanced crystalloid–colloid or unbalanced crystalloid solution on base excess. J Int Med Res 42 (2014), 468–486.